TY - JOUR AU - Albanell, J. AU - Baselga, J. PY - 1999 DA - 1999// TI - Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer JO - Drugs Today (Barc) VL - 35 ID - Albanell1999 ER - TY - JOUR AU - Spector, N. L. AU - Blackwell, K. L. PY - 2009 DA - 2009// TI - Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2009.22.1507 DO - 10.1200/JCO.2009.22.1507 ID - Spector2009 ER - TY - JOUR AU - Clynes, R. A. AU - Towers, T. L. AU - Presta, L. G. AU - Ravetch, J. V. PY - 2000 DA - 2000// TI - Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets JO - Nat Med VL - 6 UR - https://doi.org/10.1038/74704 DO - 10.1038/74704 ID - Clynes2000 ER - TY - JOUR AU - Musolino, A. AU - Naldi, N. AU - Bortesi, B. AU - Pezzuolo, D. AU - Capelletti, M. AU - Missale, G. AU - Laccabue, D. AU - Zerbini, A. AU - Camisa, R. AU - Bisagni, G. AU - Neri, T. M. AU - Ardizzoni, A. PY - 2008 DA - 2008// TI - Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.14.8957 DO - 10.1200/JCO.2007.14.8957 ID - Musolino2008 ER - TY - JOUR AU - Wilken, J. A. AU - Maihle, N. J. PY - 2010 DA - 2010// TI - Primary trastuzumab resistance: new tricks for an old drug JO - Ann N Y Acad Sci VL - 1210 UR - https://doi.org/10.1111/j.1749-6632.2010.05782.x DO - 10.1111/j.1749-6632.2010.05782.x ID - Wilken2010 ER - TY - JOUR AU - Kataoka, Y. AU - Mukohara, T. AU - Shimada, H. AU - Saijo, N. AU - Hirai, M. AU - Minami, H. PY - 2010 DA - 2010// TI - Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines JO - Ann Oncol VL - 21 UR - https://doi.org/10.1093/annonc/mdp304 DO - 10.1093/annonc/mdp304 ID - Kataoka2010 ER - TY - JOUR AU - O'Brien, N. A. AU - Browne, B. C. AU - Chow, L. AU - Wang, Y. AU - Ginther, C. AU - Arboleda, J. AU - Duffy, M. J. AU - Crown, J. AU - O'Donovan, N. AU - Slamon, D. J. PY - 2010 DA - 2010// TI - Activated phosphoinositide 3-kinase/AKT signaling confers resistance to trastuzumab but not lapatinib JO - Mol Cancer Ther VL - 9 UR - https://doi.org/10.1158/1535-7163.MCT-09-1171 DO - 10.1158/1535-7163.MCT-09-1171 ID - O'Brien2010 ER - TY - JOUR AU - Narayan, M. AU - Wilken, J. A. AU - Harris, L. N. AU - Baron, A. T. AU - Kimbler, K. D. AU - Maihle, N. J. PY - 2009 DA - 2009// TI - Trastuzumab-induced HER reprogramming in 'resistant' breast carcinoma cells JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-1056 DO - 10.1158/0008-5472.CAN-08-1056 ID - Narayan2009 ER - TY - JOUR AU - Lu, Y. AU - Zi, X. AU - Pollak, M. PY - 2004 DA - 2004// TI - Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells JO - Int J Cancer VL - 108 UR - https://doi.org/10.1002/ijc.11445 DO - 10.1002/ijc.11445 ID - Lu2004 ER - TY - JOUR AU - Shattuck, D. L. AU - Miller, J. K. AU - Carraway, K. L. AU - Sweeney, C. PY - 2008 DA - 2008// TI - Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-5962 DO - 10.1158/0008-5472.CAN-07-5962 ID - Shattuck2008 ER - TY - JOUR AU - Zhuang, G. AU - Brantley-Sieders, D. M. AU - Vaught, D. AU - Yu, J. AU - Xie, L. AU - Wells, S. AU - Jackson, D. AU - Muraoka-Cook, R. AU - Arteaga, C. AU - Chen, J. PY - 2010 DA - 2010// TI - Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-1845 DO - 10.1158/0008-5472.CAN-09-1845 ID - Zhuang2010 ER - TY - JOUR AU - Porter, R. R. PY - 1958 DA - 1958// TI - Separation and isolation of fractions of rabbit gamma-globulin containing the antibody and antigenic combining sites JO - Nature VL - 182 UR - https://doi.org/10.1038/182670a0 DO - 10.1038/182670a0 ID - Porter1958 ER - TY - JOUR AU - Nisonoff, A. AU - Wissler, F. C. AU - Lipman, L. N. PY - 1960 DA - 1960// TI - Properties of the major component of a peptic digest of rabbit antibody JO - Science VL - 132 UR - https://doi.org/10.1126/science.132.3441.1770 DO - 10.1126/science.132.3441.1770 ID - Nisonoff1960 ER - TY - JOUR AU - von Pawel-Rammingen, U. AU - Johansson, B. P. AU - Bjorck, L. PY - 2002 DA - 2002// TI - IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G JO - EMBO J VL - 21 UR - https://doi.org/10.1093/emboj/21.7.1607 DO - 10.1093/emboj/21.7.1607 ID - von Pawel-Rammingen2002 ER - TY - JOUR AU - Ryan, M. H. AU - Petrone, D. AU - Nemeth, J. F. AU - Barnathan, E. AU - Bjorck, L. AU - Jordan, R. E. PY - 2008 DA - 2008// TI - Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid JO - Mol Immunol VL - 45 UR - https://doi.org/10.1016/j.molimm.2007.10.043 DO - 10.1016/j.molimm.2007.10.043 ID - Ryan2008 ER - TY - JOUR AU - Mehta, S. K. AU - Plaut, A. G. AU - Calvanico, N. J. AU - Tomasi, T. B. PY - 1973 DA - 1973// TI - Human immunoglobulin A: production of an Fc fragment by an enteric microbial proteolytic enzyme JO - J Immunol VL - 111 ID - Mehta1973 ER - TY - JOUR AU - Senior, B. W. AU - Woof, J. M. PY - 2005 DA - 2005// TI - Effect of mutations in the human immunoglobulin A1 (IgA1) hinge on its susceptibility to cleavage by diverse bacterial IgA1 proteases JO - Infect Immun VL - 73 UR - https://doi.org/10.1128/IAI.73.3.1515-1522.2005 DO - 10.1128/IAI.73.3.1515-1522.2005 ID - Senior2005 ER - TY - JOUR AU - Brezski, R. J. AU - Vafa, O. AU - Petrone, D. AU - Tam, S. H. AU - Powers, G. AU - Ryan, M. H. AU - Luongo, J. L. AU - Oberholtzer, A. AU - Knight, D. M. AU - Jordan, R. E. PY - 2009 DA - 2009// TI - Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge JO - Proc Natl Acad Sci USA VL - 106 UR - https://doi.org/10.1073/pnas.0904174106 DO - 10.1073/pnas.0904174106 ID - Brezski2009 ER - TY - JOUR AU - Brezski, R. J. AU - Knight, D. M. AU - Jordan, R. E. PY - 2011 DA - 2011// TI - The origins, specificity, and potential biological relevance of human anti-IgG hinge autoantibodies JO - ScientificWorldJournal VL - 11 UR - https://doi.org/10.1100/tsw.2011.107 DO - 10.1100/tsw.2011.107 ID - Brezski2011 ER - TY - JOUR AU - Brezski, R. J. AU - Luongo, J. L. AU - Petrone, D. AU - Ryan, M. H. AU - Zhong, D. AU - Tam, S. H. AU - Schmidt, A. P. AU - Kruszynski, M. AU - Whitaker, B. P. AU - Knight, D. M. AU - Jordan, R. E. PY - 2008 DA - 2008// TI - Human anti-IgG1 hinge autoantibodies reconstitute the effector functions of proteolytically inactivated IgGs JO - J Immunol VL - 181 UR - https://doi.org/10.4049/jimmunol.181.5.3183 DO - 10.4049/jimmunol.181.5.3183 ID - Brezski2008 ER - TY - JOUR AU - Brezski, R. J. AU - Jordan, R. E. PY - 2010 DA - 2010// TI - Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity? JO - MAbs VL - 2 UR - https://doi.org/10.4161/mabs.2.3.11780 DO - 10.4161/mabs.2.3.11780 ID - Brezski2010 ER - TY - JOUR AU - Cooley, S. AU - Burns, L. J. AU - Repka, T. AU - Miller, J. S. PY - 1999 DA - 1999// TI - Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu JO - Exp Hematol VL - 27 UR - https://doi.org/10.1016/S0301-472X(99)00089-2 DO - 10.1016/S0301-472X(99)00089-2 ID - Cooley1999 ER - TY - JOUR AU - Mimura, K. AU - Kono, K. AU - Hanawa, M. AU - Kanzaki, M. AU - Nakao, A. AU - Ooi, A. AU - Fujii, H. PY - 2005 DA - 2005// TI - Trastuzumab-mediated antibody-dependent cellular cytotoxicity against esophageal squamous cell carcinoma JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-2476 DO - 10.1158/1078-0432.CCR-04-2476 ID - Mimura2005 ER - TY - JOUR AU - Gennari, R. AU - Menard, S. AU - Fagnoni, F. AU - Ponchio, L. AU - Scelsi, M. AU - Tagliabue, E. AU - Castiglioni, F. AU - Villani, L. AU - Magalotti, C. AU - Gibelli, N. AU - Oliviero, B. AU - Ballardini, B. AU - Da Prada, G. AU - Zambelli, A. AU - Costa, A. PY - 2004 DA - 2004// TI - Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2 JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-04-0225 DO - 10.1158/1078-0432.CCR-04-0225 ID - Gennari2004 ER - TY - JOUR AU - Arnould, L. AU - Gelly, M. AU - Penault-Llorca, F. AU - Benoit, L. AU - Bonnetain, F. AU - Migeon, C. AU - Cabaret, V. AU - Fermeaux, V. AU - Bertheau, P. AU - Garnier, J. AU - Jeannin, J. F. AU - Coudert, B. PY - 2006 DA - 2006// TI - Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism? JO - Br J Cancer VL - 94 UR - https://doi.org/10.1038/sj.bjc.6602930 DO - 10.1038/sj.bjc.6602930 ID - Arnould2006 ER - TY - JOUR AU - Varchetta, S. AU - Gibelli, N. AU - Oliviero, B. AU - Nardini, E. AU - Gennari, R. AU - Gatti, G. AU - Silva, L. S. AU - Villani, L. AU - Tagliabue, E. AU - Menard, S. AU - Costa, A. AU - Fagnoni, F. F. PY - 2007 DA - 2007// TI - Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2 JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-07-2068 DO - 10.1158/0008-5472.CAN-07-2068 ID - Varchetta2007 ER - TY - JOUR AU - Goetz, H. AU - Kuschel, M. AU - Wulff, T. AU - Sauber, C. AU - Miller, C. AU - Fisher, S. AU - Woodward, C. PY - 2004 DA - 2004// TI - Comparison of selected analytical techniques for protein sizing, quantitation and molecular weight determination JO - J Biochem Biophys Methods VL - 60 UR - https://doi.org/10.1016/j.jbbm.2004.01.007 DO - 10.1016/j.jbbm.2004.01.007 ID - Goetz2004 ER - TY - JOUR AU - Shields, R. L. AU - Lai, J. AU - Keck, R. AU - O'Connell, L. Y. AU - Hong, K. AU - Meng, Y. G. AU - Weikert, S. H. AU - Presta, L. G. PY - 2002 DA - 2002// TI - Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcγ RIII and antibody-dependent cellular toxicity JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M202069200 DO - 10.1074/jbc.M202069200 ID - Shields2002 ER - TY - JOUR AU - Zhang, N. AU - Liu, L. AU - Dan Dumitru, C. AU - Cummings, N. R. AU - Cukan, M. AU - Jiang, Y. AU - Li, Y. AU - Li, F. AU - Mitchell, T. AU - Mallem, M. R. AU - Ou, Y. AU - Patel, R. N. AU - Vo, K. AU - Wang, H. AU - Burnina, I. AU - Choi, B. K. AU - Huber, H. E. AU - Stadheim, T. A. AU - Zha, D. PY - 2011 DA - 2011// TI - Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study JO - MAbs VL - 3 UR - https://doi.org/10.4161/mabs.3.3.15532 DO - 10.4161/mabs.3.3.15532 ID - Zhang2011 ER - TY - JOUR AU - Hellman, U. AU - Wernstedt, C. AU - Gonez, J. AU - Heldin, C. H. PY - 1995 DA - 1995// TI - Improvement of an 'In-Gel' digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing JO - Anal Biochem VL - 224 UR - https://doi.org/10.1006/abio.1995.1070 DO - 10.1006/abio.1995.1070 ID - Hellman1995 ER - TY - JOUR AU - Radisky, E. S. AU - Radisky, D. C. PY - 2010 DA - 2010// TI - Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer JO - J Mammary Gland Biol Neoplasia VL - 15 UR - https://doi.org/10.1007/s10911-010-9177-x DO - 10.1007/s10911-010-9177-x ID - Radisky2010 ER - TY - JOUR AU - Vincents, B. AU - von Pawel-Rammingen, U. AU - Bjorck, L. AU - Abrahamson, M. PY - 2004 DA - 2004// TI - Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding JO - Biochemistry VL - 43 UR - https://doi.org/10.1021/bi048284d DO - 10.1021/bi048284d ID - Vincents2004 ER - TY - JOUR AU - Dufour, A. AU - Zucker, S. AU - Sampson, N. S. AU - Kuscu, C. AU - Cao, J. PY - 2010 DA - 2010// TI - Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides JO - J Biol Chem VL - 285 UR - https://doi.org/10.1074/jbc.M109.091769 DO - 10.1074/jbc.M109.091769 ID - Dufour2010 ER - TY - JOUR AU - Egeblad, M. AU - Werb, Z. PY - 2002 DA - 2002// TI - New functions for the matrix metalloproteinases in cancer progression JO - Nat Rev Cancer VL - 2 UR - https://doi.org/10.1038/nrc745 DO - 10.1038/nrc745 ID - Egeblad2002 ER - TY - JOUR AU - Gialeli, C. AU - Theocharis, A. D. AU - Karamanos, N. K. PY - 2010 DA - 2010// TI - Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting JO - FEBS J VL - 278 UR - https://doi.org/10.1111/j.1742-4658.2010.07919.x DO - 10.1111/j.1742-4658.2010.07919.x ID - Gialeli2010 ER - TY - JOUR AU - Mukherjee, S. AU - Roth, M. J. AU - Dawsey, S. M. AU - Yan, W. AU - Rodriguez-Canales, J. AU - Erickson, H. S. AU - Hu, N. AU - Goldstein, A. M. AU - Taylor, P. R. AU - Richardson, A. M. AU - Tangrea, M. A. AU - Chuaqui, R. F. AU - Emmert-Buck, M. R. PY - 2010 DA - 2010// TI - Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma JO - J Transl Med VL - 8 UR - https://doi.org/10.1186/1479-5876-8-91 DO - 10.1186/1479-5876-8-91 ID - Mukherjee2010 ER - TY - JOUR AU - Delassus, G. S. AU - Cho, H. AU - Eliceiri, G. L. PY - 2011 DA - 2011// TI - New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells JO - J Cell Physiol VL - 226 UR - https://doi.org/10.1002/jcp.22694 DO - 10.1002/jcp.22694 ID - Delassus2011 ER - TY - JOUR AU - Saridaki, Z. AU - Georgoulias, V. AU - Souglakos, J. PY - 2010 DA - 2010// TI - Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer JO - World J Gastroenterol VL - 16 UR - https://doi.org/10.3748/wjg.v16.i10.1177 DO - 10.3748/wjg.v16.i10.1177 ID - Saridaki2010 ER - TY - JOUR AU - Nagata, Y. AU - Lan, K. H. AU - Zhou, X. AU - Tan, M. AU - Esteva, F. J. AU - Sahin, A. A. AU - Klos, K. S. AU - Li, P. AU - Monia, B. P. AU - Nguyen, N. T. AU - Hortobagyi, G. N. AU - Hung, M. C. AU - Yu, D. PY - 2004 DA - 2004// TI - PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients JO - Cancer Cell VL - 6 UR - https://doi.org/10.1016/j.ccr.2004.06.022 DO - 10.1016/j.ccr.2004.06.022 ID - Nagata2004 ER - TY - JOUR AU - Johansson, B. P. AU - O., S. AU - Björck, L. PY - 2008 DA - 2008// TI - IdeS: a bacterial proteolytic enzyme with therapeutic potential JO - PLoS One VL - 3 UR - https://doi.org/10.1371/journal.pone.0001692 DO - 10.1371/journal.pone.0001692 ID - Johansson2008 ER - TY - JOUR AU - Richards, J. O. AU - Karki, S. AU - Lazar, G. A. AU - Chen, H. AU - Dang, W. AU - Desjarlais, J. R. PY - 2008 DA - 2008// TI - Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells JO - Mol Cancer Ther VL - 7 UR - https://doi.org/10.1158/1535-7163.MCT-08-0201 DO - 10.1158/1535-7163.MCT-08-0201 ID - Richards2008 ER - TY - JOUR AU - Abdullah, N. AU - Greenman, J. AU - Pimenidou, A. AU - Topping, K. P. AU - Monson, J. R. PY - 1999 DA - 1999// TI - The role of monocytes and natural killer cells in mediating antibody-dependent lysis of colorectal tumour cells JO - Cancer Immunol Immunother VL - 48 UR - https://doi.org/10.1007/s002620050600 DO - 10.1007/s002620050600 ID - Abdullah1999 ER - TY - JOUR AU - Beano, A. AU - Signorino, E. AU - Evangelista, A. AU - Brusa, D. AU - Mistrangelo, M. AU - Polimeni, M. A. AU - Spadi, R. AU - Donadio, M. AU - Ciuffreda, L. AU - Matera, L. PY - 2008 DA - 2008// TI - Correlation between NK function and response to trastuzumab in metastatic breast cancer patients JO - J Transl Med VL - 6 UR - https://doi.org/10.1186/1479-5876-6-25 DO - 10.1186/1479-5876-6-25 ID - Beano2008 ER - TY - JOUR AU - Schneider-Merck, T. AU - Lammerts van Bueren, J. J. AU - Berger, S. AU - Rossen, K. AU - van Berkel, P. H. AU - Derer, S. AU - Beyer, T. AU - Lohse, S. AU - Bleeker, W. K. AU - Peipp, M. AU - Parren, P. W. AU - van de Winkel, J. G. AU - Valerius, T. AU - Dechant, M. PY - 2010 DA - 2010// TI - Human IgG2 antibodies against epidermal growth factor receptor effectively trigger antibody-dependent cellular cytotoxicity but, in contrast to IgG1, only by cells of myeloid lineage JO - J Immunol VL - 184 UR - https://doi.org/10.4049/jimmunol.0900847 DO - 10.4049/jimmunol.0900847 ID - Schneider-Merck2010 ER - TY - JOUR AU - She, Q. B. AU - Chandarlapaty, S. AU - Ye, Q. AU - Lobo, J. AU - Haskell, K. M. AU - Leander, K. R. AU - DeFeo-Jones, D. AU - Huber, H. E. AU - Rosen, N. PY - 2008 DA - 2008// TI - Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling JO - PLoS One VL - 3 UR - https://doi.org/10.1371/journal.pone.0003065 DO - 10.1371/journal.pone.0003065 ID - She2008 ER - TY - JOUR AU - Cuello, M. AU - Ettenberg, S. A. AU - Clark, A. S. AU - Keane, M. M. AU - Posner, R. H. AU - Nau, M. M. AU - Dennis, P. A. AU - Lipkowitz, S. PY - 2001 DA - 2001// TI - Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2 JO - Cancer Res VL - 61 ID - Cuello2001 ER - TY - JOUR AU - Hurvitz, S. A. AU - Betting, D. J. AU - Stern, H. M. AU - Quinaux, E. AU - Stinson, J. AU - Seshagiri, S. AU - Zhao, Y. AU - Buyse, M. AU - Mackey, J. AU - Driga, A. AU - Damaraju, S. AU - Sliwkowski, M. X. AU - Robert, N. J. AU - Valero, V. AU - Crown, J. AU - Falkson, C. AU - Brufsky, A. AU - Pienkowski, T. AU - Eiermann, W. AU - Martin, M. AU - Bee, V. AU - Marathe, O. AU - Slamon, D. J. AU - Timmerman, J. M. PY - 2012 DA - 2012// TI - Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2294 DO - 10.1158/1078-0432.CCR-11-2294 ID - Hurvitz2012 ER - TY - JOUR AU - Qian, B. Z. AU - Pollard, J. W. PY - 2010 DA - 2010// TI - Macrophage diversity enhances tumor progression and metastasis JO - Cell VL - 141 UR - https://doi.org/10.1016/j.cell.2010.03.014 DO - 10.1016/j.cell.2010.03.014 ID - Qian2010 ER - TY - JOUR AU - Joyce, J. A. AU - Pollard, J. W. PY - 2009 DA - 2009// TI - Microenvironmental regulation of metastasis JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2618 DO - 10.1038/nrc2618 ID - Joyce2009 ER -